MTB DNA detected means a molecular test found genetic material from the Mycobacterium tuberculosis complex in the sample. This strongly suggests tuberculosis infection, but detection can reflect live bacteria or residual DNA after treatment. Clinical assessment and confirmatory tests (smear, culture, drug‑susceptibility testing) are needed to determine if disease is active and to guide appropriate therapy, including drug‑resistance evaluation.

The DNA test for tuberculosis uses nucleic acid amplification (PCR-based) methods—commonly GeneXpert—to detect Mycobacterium tuberculosis DNA directly from sputum or other samples. It delivers rapid, highly sensitive results (often within hours) and can identify key drug-resistance markers such as rifampicin resistance, guiding timely treatment decisions. It's used alongside clinical assessment and other tests to confirm active TB.

Yes. Mycobacterium tuberculosis is a bacterium with a single circular double‑stranded DNA chromosome of about 4.4 million base pairs that encodes roughly 4,000 genes. Its DNA is organized in a bacterial nucleoid (not a nucleus) and directs replication, metabolism and virulence. Some strains may carry additional mobile genetic elements, but the primary genome resides on that chromosome.

MTB DNA PCR (Mycobacterium tuberculosis PCR) is a rapid molecular test that detects MTB complex DNA in clinical samples (sputum, BAL, tissue). It provides faster, more sensitive detection than microscopy, aiding early TB diagnosis. PCR can detect bacterial DNA even from nonviable organisms and may be combined with assays for drug-resistance markers (e.g., rifampicin). Negative PCR doesn’t fully exclude TB; culture and clinical correlation remain important.

Yes. Pulmonary tuberculosis caused by Mycobacterium tuberculosis is usually curable with appropriate multi‑drug antibiotic therapy—typically a 6‑month regimen for drug‑susceptible TB—if patients complete treatment. Drug‑resistant forms (MDR/XDR) require longer, more complex regimens and specialist care and are harder to cure. Latent TB can be treated to prevent active disease. Early diagnosis, adherence and medical supervision are essential.

Mycobacterium tuberculosis primarily infects the lungs, causing persistent cough, chest pain, fever, night sweats, weight loss and lung tissue damage with granulomas and cavity formation. It survives inside macrophages, provoking a chronic immune response. TB can remain latent or reactivate, and may spread via blood or lymph to cause extrapulmonary disease—bones, kidneys, lymph nodes, and central nervous system (meningitis), causing severe illness.